Logo image
Sign in
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Journal article   Open access  Peer reviewed

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Matthew T Roe, Qian H Li, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Shaun G Goodman, Robert A Harrington, J Wouter Jukema, Patricio Lopez-Jaramillo, Renato D Lopes, …
11/05/2019

Abstract

acute coronary syndrome ADDING EZETIMIBE alirocumab BENEFIT Cardiac & Cardiovascular Systems CARDIOVASCULAR OUTCOMES Cardiovascular System & Cardiology dyslipidemias EVENTS guideline Life Sciences & Biomedicine PCSK9 Peripheral Vascular Disease Science & Technology STATIN THERAPY
url
https://doi.org/10.1161/circulationaha.119.042551View
Published (Version of record) Open

Metrics

4 Record Views

Details